Clinical Trials
22 trialsNCT05453006 2025-07-10
Isbaar
University of Minnesota
Phase NA Completed
NCT00238355 2025-04-27
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT04843566 2025-04-15
PREVENT
Weill Medical College of Cornell University
Phase NA Completed
NCT01943409 2025-02-03
Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils
University Health Network, Toronto
Phase 4 Completed
NCT05496231 2025-02-03
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
GlaxoSmithKline
Phase 1/2 Completed
NCT03960463 2025-01-23
EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds
Baylor College of Medicine
Phase NA Completed
NCT04091672 2024-07-30
RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
Avita Medical
Phase NA Completed
NCT00513526 2023-11-14
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
AIDS Malignancy Consortium
Phase 2 Completed
NCT02231879 2023-04-07
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
National Institutes of Health Clinical Center (CC)
Phase 2/3 Completed
NCT00075803 2023-01-04
BMT CTN 0101
Medical College of Wisconsin
Phase 3 Completed
NCT02496676 2022-03-02
Magnesium Supplementation in People With XMEN Syndrome
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00261807 2022-01-27
Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
University of Maryland, Baltimore
Phase NA Completed
NCT02108522 2021-07-20
CHARMS
AlloVir
Phase NA Completed
NCT00481767 2020-11-17
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
GlaxoSmithKline
Phase 3 Completed
NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT02351258 2020-05-20
CCLIP
Johns Hopkins University
Phase NA Completed
NCT01321879 2019-12-27
Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01287013 2018-01-05
Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures
National Institutes of Health Clinical Center (CC)
Phase NA Terminated
NCT00335478 2017-05-09
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
OHSU Knight Cancer Institute
Phase 2 Completed
NCT00002850 2015-11-11
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
University of Rochester
Phase 3 Completed
NCT01204788 2015-06-10
Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00589563 2014-09-10
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
City of Hope Medical Center
Phase 2 Completed